Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Delord

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Cell Stem Cell|June 12, 2012
Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cellsRaphael Ceccaldi, Kalindi Parmar, Enguerran Mouly, et al.
The Journal of Investigative Dermatology|January 21, 2020
MDA5<sup>+</sup> Dermatomyositis Is Associated with Stronger Skin Type I Interferon Transcriptomic Signature with Upregulation of IFN-κ TranscriptCharles Cassius, Reyhan Amode, Marc Delord, et al.
Immunity|October 19, 2017
Molecular and Functional Characterization of Lymphoid Progenitor Subsets Reveals a Bipartite Architecture of Human LymphopoiesisKutaiba Alhaj Hussen, Thien-Phong Vu Manh, Fabien Guimiot, et al.
American Journal of Hematology|April 28, 2021
Prolonged in-hospital stay and higher mortality after Covid-19 among patients with non-Hodgkin lymphoma treated with B-cell depleting immunotherapyRémy Duléry, Sylvain Lamure, Marc Delord, et al.
Pharmaceutics|August 26, 2022
Imatinib Optimized Therapy Improves Major Molecular Response Rates in Patients with Chronic Myeloid LeukemiaHyacinthe Johnson-Ansah, Benjamin Maneglier, Françoise Huguet, et al.
Science Signaling|October 29, 2024
CXCR4 signaling determines the fate of hematopoietic multipotent progenitors by stimulating mTOR activity and mitochondrial metabolismVincent Rondeau, Maria Kalogeraki, Lilian Roland, et al.
Cancer Discovery|September 30, 2018
Deletion 6q Drives T-cell Leukemia Progression by Ribosome ModulationStéphanie Gachet, Tiama El-Chaar, David Avran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2022
Frequency and Genomic Aspects of Intrinsic Resistance to Vismodegib in Locally Advanced Basal Cell CarcinomaAndrey A Yurchenko, Oltin T Pop, Meriem Ighilahriz, et al.
Blood|April 29, 2016
Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome-positive ALLPhilippe Rousselot, Marie Magdelaine Coudé, Nicola Gokbuget, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 20, 2024
Randomized trial investigating the utility of a liver tissue transcriptional biomarker in identifying adult liver transplant recipients not requiring maintenance immunosuppressionJulien Vionnet, Jorge Torres-Yaguana, Rosa Miquel, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Cell Stem Cell|June 12, 2012
Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cellsRaphael Ceccaldi, Kalindi Parmar, Enguerran Mouly, et al.
The Journal of Investigative Dermatology|January 21, 2020
MDA5<sup>+</sup> Dermatomyositis Is Associated with Stronger Skin Type I Interferon Transcriptomic Signature with Upregulation of IFN-κ TranscriptCharles Cassius, Reyhan Amode, Marc Delord, et al.
Immunity|October 19, 2017
Molecular and Functional Characterization of Lymphoid Progenitor Subsets Reveals a Bipartite Architecture of Human LymphopoiesisKutaiba Alhaj Hussen, Thien-Phong Vu Manh, Fabien Guimiot, et al.
American Journal of Hematology|April 28, 2021
Prolonged in-hospital stay and higher mortality after Covid-19 among patients with non-Hodgkin lymphoma treated with B-cell depleting immunotherapyRémy Duléry, Sylvain Lamure, Marc Delord, et al.
Pharmaceutics|August 26, 2022
Imatinib Optimized Therapy Improves Major Molecular Response Rates in Patients with Chronic Myeloid LeukemiaHyacinthe Johnson-Ansah, Benjamin Maneglier, Françoise Huguet, et al.
Science Signaling|October 29, 2024
CXCR4 signaling determines the fate of hematopoietic multipotent progenitors by stimulating mTOR activity and mitochondrial metabolismVincent Rondeau, Maria Kalogeraki, Lilian Roland, et al.
Cancer Discovery|September 30, 2018
Deletion 6q Drives T-cell Leukemia Progression by Ribosome ModulationStéphanie Gachet, Tiama El-Chaar, David Avran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2022
Frequency and Genomic Aspects of Intrinsic Resistance to Vismodegib in Locally Advanced Basal Cell CarcinomaAndrey A Yurchenko, Oltin T Pop, Meriem Ighilahriz, et al.
Blood|April 29, 2016
Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome-positive ALLPhilippe Rousselot, Marie Magdelaine Coudé, Nicola Gokbuget, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 20, 2024
Randomized trial investigating the utility of a liver tissue transcriptional biomarker in identifying adult liver transplant recipients not requiring maintenance immunosuppressionJulien Vionnet, Jorge Torres-Yaguana, Rosa Miquel, et al.
Pageof 7